![Krzysztof Matyjaszewski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Krzysztof Matyjaszewski
Fondatore presso Biohybrid Solutions Holding, Inc.
Posizioni attive di Krzysztof Matyjaszewski
Società | Posizione | Inizio | Fine |
---|---|---|---|
Carnegie Mellon University
![]() Carnegie Mellon University Other Consumer ServicesConsumer Services Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania. | Corporate Officer/Principal | 11/03/2010 | - |
Biohybrid Solutions Holding, Inc.
![]() Biohybrid Solutions Holding, Inc. BiotechnologyHealth Technology Biohybrid Solutions Holding, Inc. is a company that focuses on delivering safe and effective biologic drugs to patients worldwide. The company has partnered with the US government on a $38m DTRA program, which includes the discovery, manufacturing, testing, and scale-up of nanoarmored™ drugs. The company is based in Sharpsburg, PA. The company's world-renowned scientists are spearheading innovations in protein therapeutics by solving a problem facing the pharmaceutical industry: how to create longer-lived, more effective medicine. The company has developed the immunocontrol ™ platform, which can be used for epitopetargeting ™ and epitopeaccentuation ™, allowing for the discovery of new drugs against secondary, silent epitopes. The company has also modified cancer-fighting mini-proteins to increase pharmacokinetics. Biohybrid Solutions Holding was founded in 2016 by Antonina Simakova, Alan Russell, and Krzysztof Matyjaszewski. Jean Pineault has been the CEO of the company since 2021. | Fondatore | - | - |
Corporate Officer/Principal | - | - |
Storia della carriera di Krzysztof Matyjaszewski
Precedenti posizioni note di Krzysztof Matyjaszewski
Società | Posizione | Inizio | Fine |
---|---|---|---|
Pilot Polymer Technologies, Inc. (Pennsylvania)
![]() Pilot Polymer Technologies, Inc. (Pennsylvania) Chemicals: SpecialtyProcess Industries Pilot Polymer Technologies, Inc. designs and manufactures specialty polymers. It offers block copolymers, polymeric materials, methacrylates, acrylates, styrenes, vinyl pyridine reagents, ligands and catalyst removal resins. The company was founded by Krzysztof Matyjaszewski, Patrick McCarthy and James Spanswick in 2006 and is headquartered in Pittsburgh, PA. | Direttore Tecnico/Scientifico/R&S | 11/03/2010 | - |
Fondatore | 11/03/2010 | - |
Statistiche
Distribuzione geografica
Stati Uniti | 4 |
Posizioni
Corporate Officer/Principal | 2 |
Founder | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Settori
Process Industries | 2 |
Consumer Services | 2 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Pilot Polymer Technologies, Inc. (Pennsylvania)
![]() Pilot Polymer Technologies, Inc. (Pennsylvania) Chemicals: SpecialtyProcess Industries Pilot Polymer Technologies, Inc. designs and manufactures specialty polymers. It offers block copolymers, polymeric materials, methacrylates, acrylates, styrenes, vinyl pyridine reagents, ligands and catalyst removal resins. The company was founded by Krzysztof Matyjaszewski, Patrick McCarthy and James Spanswick in 2006 and is headquartered in Pittsburgh, PA. | Process Industries |
Biohybrid Solutions Holding, Inc.
![]() Biohybrid Solutions Holding, Inc. BiotechnologyHealth Technology Biohybrid Solutions Holding, Inc. is a company that focuses on delivering safe and effective biologic drugs to patients worldwide. The company has partnered with the US government on a $38m DTRA program, which includes the discovery, manufacturing, testing, and scale-up of nanoarmored™ drugs. The company is based in Sharpsburg, PA. The company's world-renowned scientists are spearheading innovations in protein therapeutics by solving a problem facing the pharmaceutical industry: how to create longer-lived, more effective medicine. The company has developed the immunocontrol ™ platform, which can be used for epitopetargeting ™ and epitopeaccentuation ™, allowing for the discovery of new drugs against secondary, silent epitopes. The company has also modified cancer-fighting mini-proteins to increase pharmacokinetics. Biohybrid Solutions Holding was founded in 2016 by Antonina Simakova, Alan Russell, and Krzysztof Matyjaszewski. Jean Pineault has been the CEO of the company since 2021. | Health Technology |